Importantly, we identified the direct targets of EN1 in PDA and elucidated the effect of EN1 in pancreatic cancer epigenome, which provides path to develop novel and exploitable drug targets in the future. This evidence concerns the gene EN1 and familial pancreatic carcinoma.